Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ BlackRock Capital Allocation Trust (BCAT) Stock Forecast & Price Prediction United States | NYSE | Financial Services | Asset Management
$15.77
+0.31 (2.01%)Did BCAT Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if BlackRock CAT is one of their latest high-conviction picks.
BCAT has shown a year-to-date change of 11.4% and a 1-year change of 3.8%, reflecting upward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for BCAT. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for BCAT.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
The following stocks are similar to BlackRock CAT based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
BlackRock Capital Allocation Trust has a market capitalization of $1.62B with a P/E ratio of 7.3x. The company generates $223.60M in trailing twelve-month revenue with a 0.0% profit margin.
Revenue growth is N/A quarter-over-quarter, while maintaining an operating margin of 0.0% and return on equity of +13.9%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Closed-end investment fund offering diversified returns.
The company operates as a closed-end investment fund that generates revenue by managing a diversified portfolio of global equities, fixed income instruments, and private investments. It aims to provide total return and income through a balanced allocation strategy, adjusting investments based on market conditions to optimize returns for investors.
BlackRock Capital Allocation Trust differentiates itself with an unconstrained, multi-asset approach and incorporates risk management tools and periodic share buyback programs. It also plans a liquidity event at net asset value in 2032, making it an appealing option for investors seeking combined exposure to equity, bond, and private markets.
BlackRock announced multiple funds, including BCX, BDJ, BGR, BGY, BME, BMEZ, BOE, and BUI, listed on NYSE, focusing on resources, equity dividends, energy, health sciences, and infrastructure.
The listing of multiple BlackRock trusts signals potential investment opportunities in diverse sectors like resources, health sciences, and utilities, which may attract interest from risk-averse investors.
The BlackRock Capital Allocation Term Trust (BCAT) has a 20% managed distribution rate, but this may pressure NAV if returns falter due to high ROC and weak price appreciation.
The high distribution rate of BCAT may attract income-focused investors, but concerns over NAV erosion and weak price appreciation could signal potential risks to returns.
BlackRock Capital Allocation Term Trust (BCAT) offers a diversified income strategy and trades at a discount to NAV, presenting a potential value opportunity, though distribution cuts are a risk.
BlackRock Capital Allocation Term Trust's discount to NAV signals potential value for income-seeking investors, while its distribution policy highlights yield sustainability versus risk of cuts.
BlackRock Capital Allocation Term Trust offers a 22% yield, focusing on total return. Its diversified portfolio reduces risk, but net investment income may not cover distributions, and share price has declined.
BCAT's high yield attracts income-seeking investors, but its focus on total return and past share price decline may signal underlying risks, impacting long-term investment strategies.
BlackRock closed-end funds announced the renewal of their discount management programs, intending to repurchase common shares via tender offers under specific conditions.
Renewal of discount management programs signals potential share price stability and investor confidence, influencing demand and valuation of BlackRock's closed-end funds.
BlackRock closed-end funds will repurchase at least 5% of outstanding shares if trading discounts to NAV exceed 10% during the measurement period.
The announcement of share repurchases by BlackRock's closed-end funds signals potential support for share prices, indicating a commitment to improving shareholder value.
Analyst forecasts for BlackRock Capital Allocation Trust (BCAT) are not currently available. The stock is trading at $15.77.
Analyst ratings for BCAT are not currently available. The stock is currently trading at $15.77. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
Price predictions from Wall Street analysts for BCAT are not currently available. The stock is trading at $15.77.
The company operates as a closed-end investment fund that generates revenue by managing a diversified portfolio of global equities, fixed income instruments, and private investments. It aims to provide total return and income through a balanced allocation strategy, adjusting investments based on market conditions to optimize returns for investors.
Price targets from Wall Street analysts for BCAT are not currently available. The stock is trading at $15.77.
Price targets from Wall Street analysts for BCAT are not currently available. The stock is trading at $15.77.
Analyst ratings for BCAT are not currently available. The stock is trading at $15.77.
Stock price projections, including those for BlackRock Capital Allocation Trust, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.